Status: current, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3643176013 | Benralizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3643177016 | Benralizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Benralizumab | Is a | Interleukin receptor antagonist | true | Inferred relationship | Some | ||
| Benralizumab | Has disposition | Interleukin receptor antagonist | true | Inferred relationship | Some | ||
| Benralizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Benralizumab only product | Has active ingredient | True | Benralizumab | Inferred relationship | Some | 1 |
| Benralizumab only product in parenteral dose form | Has active ingredient | True | Benralizumab | Inferred relationship | Some | 1 |
| Benralizumab 30 mg/mL solution for injection | Has BoSS | True | Benralizumab | Inferred relationship | Some | 1 |
| Benralizumab 30 mg/mL solution for injection | Has precise active ingredient | True | Benralizumab | Inferred relationship | Some | 1 |
| Benralizumab-containing product | Has active ingredient | True | Benralizumab | Inferred relationship | Some | 1 |
| Benralizumab-containing product in parenteral dose form | Has active ingredient | True | Benralizumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR